ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)
Conditions: Alopecia Areata; Alopecia Universalis; Alopecia Totalis Intervention: Drug: ATI 502 0.46% Topical Solution Sponsor: Aclaris Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials